FDA Invokana Study Finds Potential Amputation Link
![FDA](https://drugreporter.com/wp-content/uploads/2014/04/1-b-img-140x120.png)
The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »